U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. SPY
9. EVMN
10. AAPL

Go back to U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
(NYSE: TAK) Delayed: 18.26 -0.06 (0.33%)
Previous Close $18.32    52 Week High $0.55 
Open $18.18    52 Week Low $0.55 
Day High $18.35    P/E N/A 
Day Low $18.15    EPS $-0.20 
Volume 403,845